SofWave Medical Ltd. (TLV:SOFW)
Israel
· Delayed Price · Currency is ILS · Price in ILA | Market Cap | 1.56B |
| Revenue (ttm) | 279.39M |
| Net Income (ttm) | 17.49M |
| Shares Out | 36.12M |
| EPS (ttm) | 0.45 |
| PE Ratio | 97.02 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 69,245 |
| Average Volume | 88,545 |
| Open | 4,422.00 |
| Previous Close | 4,422.00 |
| Day's Range | 4,274.00 - 4,423.00 |
| 52-Week Range | 1,574.00 - 4,644.00 |
| Beta | 0.66 |
| RSI | 62.35 |
| Earnings Date | Mar 17, 2026 |
About SofWave Medical
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. The company offers an ultrasound technology that induces coagulation and subsequent revitalization for regenerated skin under the SUPERB brand; and non-invasive muscle toning technology under the Pure Impact VIP brand. It se... [Read more]
News
SofWave Medical Earnings Call Transcript: Q4 2025
Revenue grew 58% year-over-year in Q4 and 47% for the full year, with ongoing usage fees now 43% of total revenue. Achieved IFRS profitability, strong gross margins, and expanding global footprint, driven by demand for regenerative, non-invasive treatments.
SofWave Medical Transcript: CG MedTech, Diagnostics and Digital Health & Services Forum
Record Q3 revenue and strong profitability were driven by recurring virtual consumable sales and global expansion. Innovative non-invasive technology, high customer satisfaction, and a growing GLP-1 patient segment are fueling demand and supporting a robust financial outlook.
SofWave Medical Transcript: Jefferies London Healthcare Conference 2025
Exceptional revenue growth and profitability have been achieved, driven by proprietary technology, recurring revenue, and global expansion. Demand for non-invasive treatments is rising, with strong brand awareness and high provider satisfaction supporting continued growth.
SofWave Medical Transcript: Stifel 2025 Healthcare Conference
Record revenue growth, strong recurring revenue from virtual consumables, and high profitability mark recent performance. Product innovation and regulatory wins, especially in Japan, support global expansion, while GLP-1 trends drive demand for skin tightening and muscle toning.
SofWave Medical Earnings Call Transcript: Q3 2025
Q3 2025 saw 56% year-over-year revenue growth to $21.1 million, with strong recurring revenue and a 73.7% gross margin. Brand momentum, digital engagement, and regulatory tailwinds are driving adoption, while the company remains resilient amid macroeconomic and competitive challenges.
SofWave Medical Earnings Call Transcript: Q2 2025
Q2 2025 saw 43% revenue growth year-over-year, record net income, and strong recurring revenue. Gross margin exceeded 75%, with robust cash generation and expanding global presence. Demand for skin tightening and volumization remains high despite macroeconomic headwinds.
SofWave Medical Transcript: Jefferies Global Healthcare Conference 2025
Aesthetic device sales are accelerating, driven by patented non-invasive ultrasound technology, a recurring revenue model, and strong digital marketing. Recent FDA clearances and global expansion, especially in Asia, support continued growth and profitability.
SofWave Medical Earnings Call Transcript: Q1 2025
Q1 2025 revenue grew 26% year-over-year to $16.7 million, with recurring pulses up 49%. Brand awareness and demand surged, aided by organic celebrity endorsements and new market entries, notably Japan. Non-GAAP margins reached 76.4%.
SofWave Medical Transcript: Planet MicroCap Showcase: VEGAS 2025
Aesthetic device demand is surging, fueled by GLP-1 weight loss trends and global expansion, with high ROI and strong brand engagement. The company’s patented technology, recurring revenue model, and proven leadership support rapid growth and profitability.
SofWave Medical Transcript: 24th Annual Needham Virtual Healthcare Conference
Aesthetic device provider leverages proprietary ultrasound technology and a frictionless business model to drive rapid revenue growth, high margins, and global expansion. Strong brand awareness, digital marketing, and product innovation support continued market share gains and profitability.
SofWave Medical Transcript: Stifel 2024 Healthcare Conference
Non-invasive ultrasound technology and a frictionless business model are fueling double-digit growth, high customer ROI, and strong recurring revenue. Global expansion continues, with a focus on brand awareness, product innovation, and margin improvement.